Camille Khanfar
Overview
Explore the profile of Camille Khanfar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
3
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Berlanga P, Aerts I, Corradini N, Ndounga-Diakou L, Entz-Werle N, Ducassou S, et al.
Pediatr Blood Cancer
. 2024 Nov;
72(2):e31449.
PMID: 39558828
SACHA-France (NCT04477681) is a prospective real-world study that collects clinical safety and efficacy data of novel anticancer therapies prescribed off-label or on compassionate use to patients <25 years. From March...
2.
Delval A, Touitou T, Gondry-Jouet C, Khanfar C, Haraux E
Eur J Radiol
. 2024 Jun;
177:111580.
PMID: 38905801
Background: Neuroblastoma accounts for 15 % of cancer deaths in children. Complete surgical resection is associated with a higher overall survival rate but also a higher morbidity rate. An international...
3.
Bobin C, Iddir Y, Butterworth C, Masliah-Planchon J, Saint-Charles A, Bellini A, et al.
Clin Cancer Res
. 2024 May;
30(15):3316-3328.
PMID: 38787533
Purpose: The study of cell-free DNA (cfDNA) enables sequential analysis of tumor cell-specific genetic alterations in patients with neuroblastoma. Experimental Design: Eighteen patients with relapsing neuroblastoma having received lorlatinib, a...
4.
Raiser P, Schleiermacher G, Gambart M, Dumont B, Defachelles A, Thebaud E, et al.
Eur J Cancer
. 2024 Mar;
202:114001.
PMID: 38489858
Background: Addition of anti-GD2 antibodies to temozolomide-based chemotherapy has demonstrated increased antitumor activity and progression-free survival in patients with relapsed/progressive high-risk neuroblastoma. However, chemo-immunotherapy is not yet approved for this...